Aggravated hepatic fibrosis induced by phenylalanine and tyrosine was ameliorated by chitooligosaccharides supplementation

文献类型： 外文期刊

第一作者： Liu, Peng

作者： Liu, Peng;Li, Heng;Gong, Jinsong;Jiang, Min;Shi, Jinsong;Liu, Peng;Xu, Hongyu;Xu, Zhenghong

作者机构： Jiangnan Univ, Sch Life Sci & Hlth Engn, Minist Educ, Key Lab Carbohydrate Chem & Biotechnol, Wuxi 214122, Peoples R China;Shanghai Acad Agr Sci, Inst Edible Fungi, 1000 Jinqi Rd, Shanghai 201403, Peoples R China;Jiangnan Univ, Natl Engn Res Ctr Cereal Fermentat & Food Biomfg, Wuxi 214122, Peoples R China

期刊名称：ISCIENCE （ 2022影响因子：5.8； 五年影响因子：5.8 ）

ISSN：

年卷期： 2023 年 26 卷 10 期

页码：

收录情况： SCI

摘要： Hepatic fibrosis is a classic pathological manifestation of metabolic chronic hepatopathy. The pathological process might either gradually deteriorate into cirrhosis and ultimately liver cancer with inappropriate nutrition supply, or be slowed down by several multifunctional nutrients, alternatively. Herein, we found diet with excessive phenylalanine (Phe) and tyrosine (Tyr) exacerbated hepatic fibrosis symptoms of liver dysfunction and gut microflora dysbiosis in mice. Chitooligosaccharides (COS) could ameliorate hepatic fibrosis with the regulation of amino acid metabolism by downregulating the mTORC1 pathway, especially that of Phe and Tyr, and also with the alleviation of the dysbiosis of gut microbiota, simultaneously. Conclusively, this work presents new insight into the role of Phe and Tyr in the pathologic process of hepatic fibrosis, while revealing the effectiveness and molecular mechanism of COS in improving hepatic fibrosis from the perspective of metabolites.

分类号：

  • 相关文献
作者其他论文 更多>>

微信小程序